Journal of dermatological science最新文献

筛选
英文 中文
Editors choice 编辑推荐
IF 4.6
Journal of dermatological science Pub Date : 2024-10-01 DOI: 10.1016/S0923-1811(24)00207-X
{"title":"Editors choice","authors":"","doi":"10.1016/S0923-1811(24)00207-X","DOIUrl":"10.1016/S0923-1811(24)00207-X","url":null,"abstract":"","PeriodicalId":94076,"journal":{"name":"Journal of dermatological science","volume":"116 1","pages":"Page 1"},"PeriodicalIF":4.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142527587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ferrostatin-1 alleviates skin inflammation and inhibits ferroptosis of neutrophils and CD8+ T cells in allergic contact dermatitis 铁前列素-1 可减轻过敏性接触性皮炎的皮肤炎症反应,并抑制中性粒细胞和 CD8+ T 细胞的铁凋亡。
IF 4.6
Journal of dermatological science Pub Date : 2024-10-01 DOI: 10.1016/j.jdermsci.2024.08.004
Yangying Ke, Ni Lian, Yujie Chen, Yiqun Zhang, Yuancheng Li, Wenlan Zhang, Hui Yu, Heng Gu, Xu Chen
{"title":"Ferrostatin-1 alleviates skin inflammation and inhibits ferroptosis of neutrophils and CD8+ T cells in allergic contact dermatitis","authors":"Yangying Ke,&nbsp;Ni Lian,&nbsp;Yujie Chen,&nbsp;Yiqun Zhang,&nbsp;Yuancheng Li,&nbsp;Wenlan Zhang,&nbsp;Hui Yu,&nbsp;Heng Gu,&nbsp;Xu Chen","doi":"10.1016/j.jdermsci.2024.08.004","DOIUrl":"10.1016/j.jdermsci.2024.08.004","url":null,"abstract":"<div><h3>Background</h3><div>Ferroptosis is considered as an immunogenic type of regulated cell death and associated with the pathogenesis of inflammatory skin diseases. However, the involvement and function of ferroptosis in allergic contact dermatitis (ACD) remains unknown.</div></div><div><h3>Objective</h3><div>To explore the role of ferroptosis in ACD. To reveal which type of cells develops ferroptosis in ACD.</div></div><div><h3>Methods</h3><div>We detected the key markers of ferroptosis in 1-Chloro-2,4-dinitrochlorobenzene (DNCB)-induced ACD mice model. We applicated ferrostatin-1 (Fer-1) to restrain ferroptosis in ACD mice and then compared the severity of dermatitis and the level of inflammation and ferroptosis in dermis and epidermis, respectively. Keratinocyte-specific <em>Gpx4</em> conditional knockout (cKO) mice were used to investigate the function of keratinocyte ferroptosis in the development of ACD. Single-cell RNA sequencing was conducted to analyze the affection of Fer-1 on different type of cells in ACD.</div></div><div><h3>Results</h3><div>Ferroptosis was involved in DNCB-induced ACD mice. Ferroptosis activation was more remarkable in dermis rather than in epidermis. <em>Gpx4</em> cKO mice showed similar severity of skin dermatitis as control mice. Fer-1 alleviated skin inflammation in mice and reduced ferroptosis in neutrophils and CD8<sup>+</sup> T cells both of which contribute to development of ACD.</div></div><div><h3>Conclusion</h3><div>Ferroptosis was activated in immune cells, especially neutrophils and CD8<sup>+</sup> T cells in DNCB-induced ACD mice. Fer-1 treatment inhibited ferroptosis of neutrophils and CD8<sup>+</sup> T cells and relieved skin damage in ACD mice.</div></div>","PeriodicalId":94076,"journal":{"name":"Journal of dermatological science","volume":"116 1","pages":"Pages 2-13"},"PeriodicalIF":4.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
20240927Announcement_JDSBestPaperAward 20240927公告_JDSB最佳论文奖
IF 4.6
Journal of dermatological science Pub Date : 2024-10-01 DOI: 10.1016/S0923-1811(24)00204-4
{"title":"20240927Announcement_JDSBestPaperAward","authors":"","doi":"10.1016/S0923-1811(24)00204-4","DOIUrl":"10.1016/S0923-1811(24)00204-4","url":null,"abstract":"","PeriodicalId":94076,"journal":{"name":"Journal of dermatological science","volume":"116 1","pages":"Page 59"},"PeriodicalIF":4.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142533810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Decreased TET2/5-hmC reduces the integrity of the epidermal barrier via epigenetic dysregulation of filaggrin in psoriatic lesions” [J. Dermatol. Sci. 113 (2024) 103–112] 对 "银屑病皮损中 TET2/5-hmC 的减少通过丝胶蛋白的表观遗传失调降低了表皮屏障的完整性 "的更正 [J. Dermatol. Sci.
IF 4.6
Journal of dermatological science Pub Date : 2024-09-01 DOI: 10.1016/j.jdermsci.2024.07.003
Huan Zhang , Tao Jia , Delu Che , Bin Peng , Zhaowei Chu , Xiangjin Song , Weihui Zeng , Songmei Geng
{"title":"Corrigendum to “Decreased TET2/5-hmC reduces the integrity of the epidermal barrier via epigenetic dysregulation of filaggrin in psoriatic lesions” [J. Dermatol. Sci. 113 (2024) 103–112]","authors":"Huan Zhang ,&nbsp;Tao Jia ,&nbsp;Delu Che ,&nbsp;Bin Peng ,&nbsp;Zhaowei Chu ,&nbsp;Xiangjin Song ,&nbsp;Weihui Zeng ,&nbsp;Songmei Geng","doi":"10.1016/j.jdermsci.2024.07.003","DOIUrl":"10.1016/j.jdermsci.2024.07.003","url":null,"abstract":"","PeriodicalId":94076,"journal":{"name":"Journal of dermatological science","volume":"115 3","pages":"Pages 147-148"},"PeriodicalIF":4.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S092318112400149X/pdfft?md5=4e402410281c340edd24c5104f5dfc9a&pid=1-s2.0-S092318112400149X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141880025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revealing the UV response of melanocytes in xeroderma pigmentosum group A using patient-derived induced pluripotent stem cells 利用源自患者的诱导多能干细胞揭示 A 组色素性角化症黑色素细胞的紫外线反应。
IF 4.6
Journal of dermatological science Pub Date : 2024-09-01 DOI: 10.1016/j.jdermsci.2024.06.004
Chihiro Takemori , Michiyo Koyanagi-Aoi , Takeshi Fukumoto , Makoto Kunisada , Kazumasa Wakamatsu , Shosuke Ito , Chieko Hosaka , Seiji Takeuchi , Akiharu Kubo , Takashi Aoi , Chikako Nishigori
{"title":"Revealing the UV response of melanocytes in xeroderma pigmentosum group A using patient-derived induced pluripotent stem cells","authors":"Chihiro Takemori ,&nbsp;Michiyo Koyanagi-Aoi ,&nbsp;Takeshi Fukumoto ,&nbsp;Makoto Kunisada ,&nbsp;Kazumasa Wakamatsu ,&nbsp;Shosuke Ito ,&nbsp;Chieko Hosaka ,&nbsp;Seiji Takeuchi ,&nbsp;Akiharu Kubo ,&nbsp;Takashi Aoi ,&nbsp;Chikako Nishigori","doi":"10.1016/j.jdermsci.2024.06.004","DOIUrl":"10.1016/j.jdermsci.2024.06.004","url":null,"abstract":"<div><h3>Background</h3><p><span><span>Xeroderma pigmentosum (XP) is characterized by </span>photosensitivity<span><span> that causes pigmentary disorder and predisposition to skin cancers on sunlight-exposed areas due to </span>DNA repair deficiency. Patients with XP group A (XP-A) develop freckle-like pigmented maculae and depigmented maculae within a year unless strict sun-protection is enforced. Although it is crucial to study </span></span>pigment cells (melanocytes: MCs) as disease target cells, establishing MCs in primary cultures is challenging.</p></div><div><h3>Objective</h3><p><span>Elucidation of the disease pathogenesis by comparison between MCs differentiated from XP-A induced pluripotent stem cells (iPSCs) and healthy control iPSCs on the response to </span>UV irradiation.</p></div><div><h3>Methods</h3><p><span>iPSCs were established from a XP-A fibroblasts and differentiated into MCs. Differences in gene expression profiles between XP-A-iPSC-derived melanocytes (XP-A-iMCs) and Healthy control iPSC-derived MCs (HC-iMCs) were analyzed 4 and 12 h after irradiation with 30 or 150 J/m</span><sup>2</sup><span> of UV-B using microarray analysis.</span></p></div><div><h3>Results</h3><p><span><span>XP-A-iMCs expressed SOX10, </span>MITF<span>, and TYR, and showed melanin synthesis<span><span>. Further, XP-A-iMCs showed reduced DNA repair ability. Gene expression profile between XP-A-iMCs and HC-iMCs revealed that, numerous </span>gene probes that were specifically upregulated or downregulated in XP-A-iMCs after 150-J/m</span></span></span><sup>2</sup> of UV-B irradiation did not return to basal levels. Of note that apoptotic pathways were highly upregulated at 150 J/m<sup>2</sup> UV exposure in XP-A-iMCs, and cytokine-related pathways were upregulated even at 30 J/m<sup>2</sup> UV exposure.</p></div><div><h3>Conclusion</h3><p>We revealed for the first time that cytokine-related pathways were upregulated even at low-dose UV exposure in XP-A-iMCs. Disease-specific iPSCs are useful to elucidate the disease pathogenesis and develop treatment strategies of XP.</p></div>","PeriodicalId":94076,"journal":{"name":"Journal of dermatological science","volume":"115 3","pages":"Pages 111-120"},"PeriodicalIF":4.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141736215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cold shock therapy promotes hair growth in association with upregulation of cold-inducible RNA-binding protein and vascular endothelial growth factor 冷休克疗法促进毛发生长与冷诱导 RNA 结合蛋白和血管内皮生长因子的上调有关。
IF 4.6
Journal of dermatological science Pub Date : 2024-09-01 DOI: 10.1016/j.jdermsci.2024.08.001
Seunghee Lee , Sanseul Kim , Sungjoo Tommy Hwang , Gun-Ho Kim , Ohsang Kwon
{"title":"Cold shock therapy promotes hair growth in association with upregulation of cold-inducible RNA-binding protein and vascular endothelial growth factor","authors":"Seunghee Lee ,&nbsp;Sanseul Kim ,&nbsp;Sungjoo Tommy Hwang ,&nbsp;Gun-Ho Kim ,&nbsp;Ohsang Kwon","doi":"10.1016/j.jdermsci.2024.08.001","DOIUrl":"10.1016/j.jdermsci.2024.08.001","url":null,"abstract":"","PeriodicalId":94076,"journal":{"name":"Journal of dermatological science","volume":"115 3","pages":"Pages 141-144"},"PeriodicalIF":4.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Dual effect of tacrolimus on mast cell-mediated allergy and inflammation through MAS-related G protein-coupled receptor-X2” [J. Dermatol. Sci. 112 (2023) 128–137] 他克莫司通过 MAS 相关 G 蛋白偶联受体-X2 对肥大细胞介导的过敏和炎症的双重作用》[J. Dermatol. Sci. 112 (2023) 128-137] 更正。
IF 4.6
Journal of dermatological science Pub Date : 2024-09-01 DOI: 10.1016/j.jdermsci.2024.06.005
Xueshan Du , Delu Che , Bin Peng , Yi Zheng , Yong Hao , Tao Jia , Xinyue Zhang , Songmei Geng
{"title":"Corrigendum to “Dual effect of tacrolimus on mast cell-mediated allergy and inflammation through MAS-related G protein-coupled receptor-X2” [J. Dermatol. Sci. 112 (2023) 128–137]","authors":"Xueshan Du ,&nbsp;Delu Che ,&nbsp;Bin Peng ,&nbsp;Yi Zheng ,&nbsp;Yong Hao ,&nbsp;Tao Jia ,&nbsp;Xinyue Zhang ,&nbsp;Songmei Geng","doi":"10.1016/j.jdermsci.2024.06.005","DOIUrl":"10.1016/j.jdermsci.2024.06.005","url":null,"abstract":"","PeriodicalId":94076,"journal":{"name":"Journal of dermatological science","volume":"115 3","pages":"Pages 145-146"},"PeriodicalIF":4.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923181124001385/pdfft?md5=380049bd5002a76a77f44bf2926f67ec&pid=1-s2.0-S0923181124001385-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141861984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Semaxanib, a VEGF inhibitor, suppresses melanogenesis by modulating CRTC3 independently of VEGF signaling 塞马沙尼(一种血管内皮生长因子抑制剂)通过调节 CRTC3(独立于血管内皮生长因子信号)抑制黑色素生成
IF 4.6
Journal of dermatological science Pub Date : 2024-09-01 DOI: 10.1016/j.jdermsci.2024.07.004
HyeJi Kwon , Jeong Hyeon Lee , Jae Min Yoo , Huonggiang Nguyen , Hongchan An , Sung Eun Chang , Youngsup Song
{"title":"Semaxanib, a VEGF inhibitor, suppresses melanogenesis by modulating CRTC3 independently of VEGF signaling","authors":"HyeJi Kwon ,&nbsp;Jeong Hyeon Lee ,&nbsp;Jae Min Yoo ,&nbsp;Huonggiang Nguyen ,&nbsp;Hongchan An ,&nbsp;Sung Eun Chang ,&nbsp;Youngsup Song","doi":"10.1016/j.jdermsci.2024.07.004","DOIUrl":"10.1016/j.jdermsci.2024.07.004","url":null,"abstract":"<div><h3>Background</h3><p>Dysregulation of melanogenesis contributes to the development of skin hyperpigmentation diseases, which poses a treatment challenge. Following the establishment of CRTC3 screening methods to explore small molecules inhibiting melanogenesis for the topical treatment of hyperpigmentation diseases, we identified a candidate molecule, semaxanib.</p></div><div><h3>Objective</h3><p>To explore the antimelanogenic effects of semaxanib, a vascular endothelial growth factor receptor (VEGFR) 2 inhibitor, for potential applications in hyperpigmentation management and to unravel the role of VEGF signaling in melanocyte biology by investigating mechanism of action of semaxanib.</p></div><div><h3>Methods</h3><p>Mouse-derived spontaneously immortalized melanocytes, B16F10, and normal human primary epidermal melanocytes cells were treated with semaxanib, and cellular responses were assessed using cell viability assays and melanin content measurements. Molecular mechanisms were investigated using transcriptional activity assays, reverse-transcription polymerase chain reaction, and immunoblotting analysis. <em>In vivo</em> studies were conducted using an epidermis-humanized transgenic mouse model and <em>ex vivo</em> human skin tissues.</p></div><div><h3>Results</h3><p>Semaxanib ameliorated melanin content in cultured melanocytes by downregulating the expression of melanogenesis-associated genes by suppressing the CRTC3/microphthalmia-associated transcription factors. Topical application of semaxanib reduced melanin accumulation in the ultraviolet B–stimulated <em>ex vivo</em> human epidermis and tail of K14-stem cell factor transgenic mice. Mechanistically, the antimelanogenic effect induced by semaxanib was associated with SIK2-CRTC3-MITF rather than VEGF signaling in melanocytes.</p></div><div><h3>Conclusion</h3><p>Semaxanib emerges as a promising candidate for the development of therapeutics for hyperpigmentation, potentially working independently of VEGF signaling in human melanocytes.</p></div>","PeriodicalId":94076,"journal":{"name":"Journal of dermatological science","volume":"115 3","pages":"Pages 121-129"},"PeriodicalIF":4.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141845138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
JSID flier with late breaking announce 联合材料与发展倡议传单,内含最新消息
IF 4.6
Journal of dermatological science Pub Date : 2024-09-01 DOI: 10.1016/S0923-1811(24)00186-5
{"title":"JSID flier with late breaking announce","authors":"","doi":"10.1016/S0923-1811(24)00186-5","DOIUrl":"10.1016/S0923-1811(24)00186-5","url":null,"abstract":"","PeriodicalId":94076,"journal":{"name":"Journal of dermatological science","volume":"115 3","pages":"Page I"},"PeriodicalIF":4.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142244197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exposure to volatile ferroptosis inhibitor, TEMPO, reduced cutaneous ischemia-reperfusion injury progression to pressure ulcer formation in a mouse model 在小鼠模型中暴露于挥发性铁素体抑制剂 TEMPO,可减少皮肤缺血再灌注损伤进展为压疮的形成
IF 4.6
Journal of dermatological science Pub Date : 2024-09-01 DOI: 10.1016/j.jdermsci.2024.07.005
Mai Ishikawa , Akihiko Uchiyama , Keiji Kosaka , Mayu Nishio , Sachiko Ogino , Yoko Yokoyama , Ryoko Torii , Ryoko Akai , Takao Iwawaki , Seiji Torii , Sei-ichiro Motegi
{"title":"Exposure to volatile ferroptosis inhibitor, TEMPO, reduced cutaneous ischemia-reperfusion injury progression to pressure ulcer formation in a mouse model","authors":"Mai Ishikawa ,&nbsp;Akihiko Uchiyama ,&nbsp;Keiji Kosaka ,&nbsp;Mayu Nishio ,&nbsp;Sachiko Ogino ,&nbsp;Yoko Yokoyama ,&nbsp;Ryoko Torii ,&nbsp;Ryoko Akai ,&nbsp;Takao Iwawaki ,&nbsp;Seiji Torii ,&nbsp;Sei-ichiro Motegi","doi":"10.1016/j.jdermsci.2024.07.005","DOIUrl":"10.1016/j.jdermsci.2024.07.005","url":null,"abstract":"<div><h3>Background</h3><p>Ischemia– reperfusion (I/R) injury-induced oxidative stress is a key factor in the pathogenesis of pressure ulcer formation. Ferroptosis is an iron-dependent programmed cell death that connects oxidative stress and inflammation in various diseases. Recent studies revealed the protective effect of inhibition of ferroptosis in I/R injury. However, the role of ferroptosis in cutaneous I/R injury remains elusive.</p></div><div><h3>Objective</h3><p>To assess the role of ferroptosis in the progression of cutaneous I/R injury.</p></div><div><h3>Methods</h3><p>Cutaneous I/R injury experiments and histopathological studies were performed in wild-type mice with or without exposure to volatile ferroptosis inhibitor, TEMPO (2,2,6,6-Tetramethylpiperidine-1-oxyl). The suppressive effects of TEMPO on ferroptosis inducing cell death and oxidative stress were examined <em>in vitro</em>.</p></div><div><h3>Results</h3><p>Inhibition of ferroptosis with TEMPO significantly reduced ulcer formation after cutaneous I/R injury. Fluctuated ferroptosis markers, such as GPX4, ACSL4, and 4-HNE expression in the I/R skin site, were reversed by TEMPO treatment. Inhibition of ferroptosis reduced apoptosis, CD3<sup>+</sup> infiltrating lymphocytes, and improved vascularity in the I/R skin site. Inhibition of ferroptosis also suppressed the enhancement of Nrf2 activation. <em>In vitro</em>, ferroptosis and the activation of ferroptosis-related gene expression by RSL3 stimulation were markedly ameliorated by TEMPO treatment in mouse fibroblasts. Inhibiting ferroptosis also suppressed the elevation of the mRNA levels of NOX2 and HO-1 caused by ferroptosis.</p></div><div><h3>Conclusion</h3><p>Cutaneous I/R injury-induced ferroptosis likely promotes cell death, vascular loss, infiltration of inflammatory cells, and oxidative stress. The inhibition of ferroptosis with TEMPO might have potential clinical application as novel therapeutic agent for cutaneous I/R injury.</p></div>","PeriodicalId":94076,"journal":{"name":"Journal of dermatological science","volume":"115 3","pages":"Pages 130-140"},"PeriodicalIF":4.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923181124001518/pdfft?md5=ada58dbe07a87acdcb729adcccd7d6b0&pid=1-s2.0-S0923181124001518-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141853815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信